Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy (Q34187436)
scientific article
Language:
Current Data About Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
(P31) (Q13442814)
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

(P304) 17-23
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

(P433) 1
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

(P478) 38
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

(P577) Sunday, April 1, 2001
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

(P921) (Q79460)
(P887)

(Q422248)
(P887)

(P1433) (Q15724423)
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

(P1476) "Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy" (language: en)
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

(P2093) X D Yang
(P1545) 1
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

X C Jia
(P1545) 2
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

J R Corvalan
(P1545) 3
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

P Wang
(P1545) 4
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

C G Davis
(P1545) 5
(P248)
(P698) 11255078
(P813) Monday, July 31, 2017

(P2860) (Q26776979)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q28290936)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q36182058)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q46643016)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q41565454)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q46760824)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q42182267)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q37220614)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q28293442)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q42805935)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q69856767)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q40585866)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q41702457)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q35975667)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(Q35975727)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900134-7
(P813) Thursday, January 7, 2021
(P887)

(P13046) (Q7318358)
(P248)

other details
description scientific article

External Links
(P356) 10.1016/S1040-8428(00)00134-7
(P698) 11255078